Document Detail

Haemodynamic and metabolic effects of the antiarrhythmic drug melperone during acute left ventricular failure in dogs.
MedLine Citation:
PMID:  7326689     Owner:  NLM     Status:  MEDLINE    
Haemodynamic and metabolic effects of the new antiarrhythmic drug melperone were studied during acute ischaemic left ventricular failure in closed-chest anaesthetized dogs. Embolisation of the left main coronary artery with 50 micrometer plastic microspheres induced severe depression of left ventricular performance as evidenced by a marked increase in left ventricular end-diastolic pressure and a marked reduction in the maximum rate of left ventricular pressure rise (LVdP/dtmax), cardiac output, and stroke volume. Six dogs received intravenous melperone 1.0 and 2.5 mg . kg-1 (cumulative dose) 90 and 115 min after the embolisation, respectively. Six other dogs received no treatment and served as controls. Melperone effected a marked reduction in left ventricular end-diastolic pressure, a slight but transient increase in LVdP/dtmax, a moderate reduction in heart rate, a moderate reduction in mean aortic blood pressure and total peripheral resistance and a moderate increase in stroke volume. Melperone moderately decreased myocardial O2-consumption, while myocardial lactate uptake remained unchanged. In conclusion, in contrast to commonly used antiarrhythmic drugs which may all induce cardiodepression, melperone improved left ventricular function in dogs with acute ischaemic left ventricular failure.
O A Smiseth; E S Platou; H Refsum; O D Mjøs
Related Documents :
22668069 - Mitochondrial pathways, permeability transition pore and redox signaling in cardioprote...
2978809 - Evaluation of reperfusion hyperemia with myocardial contrast echocardiography.
16210139 - Long-term therapy with the acorn cardiac support device normalizes gene expression of g...
7388859 - Migration of 15 micron microspheres from infarcted myocardium.
6859279 - A nonsurgical canine model of chronic left ventricular myocardial dysfunction.
7215379 - External detection of regional myocardial metabolism with radioiodinated hexadecenoic a...
20444469 - Do baseline atrial electrocardiographic and infarction patterns predict new-onset atria...
24804119 - Contained left ventricular free wall rupture following myocardial infarction.
24682569 - Ventricular rate monitoring as a tool to predict and prevent atrial fibrillation-relate...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Cardiovascular research     Volume:  15     ISSN:  0008-6363     ISO Abbreviation:  Cardiovasc. Res.     Publication Date:  1981 Dec 
Date Detail:
Created Date:  1982-04-12     Completed Date:  1982-04-12     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0077427     Medline TA:  Cardiovasc Res     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  724-30     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Acute Disease
Anti-Arrhythmia Agents / pharmacology*,  therapeutic use
Butyrophenones / pharmacology*,  therapeutic use
Coronary Disease / drug therapy,  metabolism,  physiopathology*
Hemodynamics / drug effects*
Myocardium / metabolism*
Oxygen Consumption / drug effects
Reg. No./Substance:
0/Anti-Arrhythmia Agents; 0/Butyrophenones; 3575-80-2/metylperon

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Electrophysiological and mechanical studies of frog heart adrenoceptor stimulation by epinine.
Next Document:  Assessment of cadmium telluride detector system for measurement of muscle blood flow during dynamic ...